Keyphrases
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
18%
Adolescent Obesity
12%
Body Mass Index
16%
Cardiovascular Risk
21%
Cognitive Decline
12%
Cognitive Dysfunction
29%
Cognitive Function
56%
Cognitive Impairment
32%
Cognitive Performance
19%
Cognitive Score
13%
Dementia
12%
Dementia Risk
11%
Diabetes
74%
Diabetes Risk
13%
Digit Symbol Substitution Test
15%
Dulaglutide
12%
During Pregnancy
12%
Dysglycemia
23%
Early-onset Type 2 Diabetes
24%
Gestational Diabetes
12%
Glargine
15%
Glucose Control
17%
Glucose Intolerance
15%
Hazard Ratio
17%
Hypoglycemia
12%
Intervention Studies
16%
Intranasal Insulin
15%
Israeli
18%
Late Adolescence
18%
Meta-analysis
15%
Metabolic Syndrome
11%
Mini-Mental State Examination
16%
Montreal Cognitive Assessment (MoCA)
12%
Morbid Obesity
13%
National Cohort Study
14%
Obesity
16%
Older Adults
41%
Older People
34%
Oral Glucose Tolerance Test
11%
Patients with Diabetes
54%
Placebo
11%
Pregestational Diabetes
11%
Randomized Controlled Trial
22%
Risk Factors
17%
Systematic Meta-analysis
15%
Thyroid Eye Disease
22%
Type 1 Diabetes Mellitus (T1DM)
34%
Type 2 Diabetes Mellitus (T2DM)
71%
Type I Diabetes
24%
Young Adulthood
16%
Medicine and Dentistry
Adolescent Obesity
6%
Apoplexy
15%
Birth Weight
8%
Body Mass Index
42%
Cardiovascular Disease
9%
Cardiovascular Risk
10%
Cardiovascular System
15%
Cognitive Defect
26%
Cohort Analysis
25%
Comorbidity
7%
Cross Sectional Study
6%
Diabetes
100%
Diabetes Mellitus
18%
Digit Symbol Substitution Test
7%
Disease Management
7%
Dulaglutide
12%
Dysglycemia
8%
Endocrine Ophthalmopathy
19%
Geriatrics
5%
Gestational Diabetes
13%
Glycemic
5%
Hazard Ratio
12%
Hypoglycemia
8%
Insulin Dependent Diabetes Mellitus
24%
Insulin Pump
7%
Linear Regression Analysis
6%
Maturity Onset Diabetes of the Young
54%
Meta-Analysis
11%
Metabolic Syndrome
11%
Mini-Mental State Examination
6%
Montreal Cognitive Assessment
11%
Morbid Obesity
7%
Myocardial Infarction
9%
Neonatal Hypoglycemia
7%
Neonate
7%
Odds Ratio
7%
Patient with Diabetes
5%
Physical Capacity
5%
Placebo
13%
Prevalence
8%
Prevention of Dementia
5%
Primary Health Care
8%
Quality of Life
9%
Randomized Controlled Trial
16%
Semaglutide
6%
Systematic Review
8%
Thyroid Stimulating Immunoglobulin
5%
Type 1 Diabetes
5%
Type 2 Diabetes
7%